A proteomic analysis identifies higher AHSG (Alpha-2-HS-glycoprotein) in saliva of oropharyngeal cancer patients – A potential salivary biomarker

Objective: Oropharyngeal cancer (OPC) is one of the most prevailing cancers worldwide with squamous cell type representing the major cases. OPC has a poor survival rate which is majorly attributed to late presentation of the disease with non-availability of a suitable tumor marker as one of the majo...

Full description

Saved in:
Bibliographic Details
Main Authors: Anu Jain, Aafaque Ahmad Khan, Rajandeep Kaur, Roshan K Verma, Jaimanti Bakshi, Aditi Chatterjee, Amanjit Bal, Sushmita Ghoshal, Arnab Pal
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Oral Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906024003248
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553713967136768
author Anu Jain
Aafaque Ahmad Khan
Rajandeep Kaur
Roshan K Verma
Jaimanti Bakshi
Aditi Chatterjee
Amanjit Bal
Sushmita Ghoshal
Arnab Pal
author_facet Anu Jain
Aafaque Ahmad Khan
Rajandeep Kaur
Roshan K Verma
Jaimanti Bakshi
Aditi Chatterjee
Amanjit Bal
Sushmita Ghoshal
Arnab Pal
author_sort Anu Jain
collection DOAJ
description Objective: Oropharyngeal cancer (OPC) is one of the most prevailing cancers worldwide with squamous cell type representing the major cases. OPC has a poor survival rate which is majorly attributed to late presentation of the disease with non-availability of a suitable tumor marker as one of the major reasons associated. This study was designed to identify a potential salivary biomarker for OPC using proteomics approach. Materials and methods: OPC cases were enrolled in different cohorts depending on the tobacco consumption habits as smokers, chewers, smokers and chewers and no tobacco consumers. Healthy controls without any tobacco consumption habits were enrolled simultaneously. Tandem Mass Tag based relative quantification was done to identify the cancer related dysregulated proteins. Dysregulated proteins were validated further in a larger cohort of cases and controls. Furthermore, the tissue expression of AHSG was analysed using the TCGA data available on cBioportal and GEPIA2. Results: 171 proteins were identified of which 135 proteins were dysregulated with ≥2-fold change. Differential expression of proteins in different OPC study cohorts was observed. 15 candidate proteins were selected for validation after analysing the data. AHSG (alpha-2HS-glycoprotein) was one of the candidates, validated in a separate larger cohort of cases and controls and was found to be significantly elevated in cases. AHSG was also found to be upregulated in the tumor tissue of HNSCC patients and patients with low AHSG were found to have the better overall survival outcome in comparison to the cases with higher AHSG. Conclusions: AHSG levels are elevated in saliva of OPC cases compared to non-OPC healthy controls. This expression pattern of AHSG should be evaluated further as a potential biomarker for OPC.
format Article
id doaj-art-f5fe072f101a49b3a753355886d3d1ec
institution Kabale University
issn 2772-9060
language English
publishDate 2024-06-01
publisher Elsevier
record_format Article
series Oral Oncology Reports
spelling doaj-art-f5fe072f101a49b3a753355886d3d1ec2025-01-09T06:16:27ZengElsevierOral Oncology Reports2772-90602024-06-0110100478A proteomic analysis identifies higher AHSG (Alpha-2-HS-glycoprotein) in saliva of oropharyngeal cancer patients – A potential salivary biomarkerAnu Jain0Aafaque Ahmad Khan1Rajandeep Kaur2Roshan K Verma3Jaimanti Bakshi4Aditi Chatterjee5Amanjit Bal6Sushmita Ghoshal7Arnab Pal8Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, IndiaInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore, Karnataka, 560066, IndiaDepartment of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, IndiaDepartment of Otolaryngology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, IndiaDepartment of Otolaryngology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, IndiaInstitute of Bioinformatics, International Tech Park, Whitefield, Bangalore, Karnataka, 560066, India; Manipal Academy of Higher Education (MAHE), Manipal, IndiaDepartment of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, IndiaDepartment of Radiotherapy, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, IndiaDepartment of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India; Corresponding author. Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.Objective: Oropharyngeal cancer (OPC) is one of the most prevailing cancers worldwide with squamous cell type representing the major cases. OPC has a poor survival rate which is majorly attributed to late presentation of the disease with non-availability of a suitable tumor marker as one of the major reasons associated. This study was designed to identify a potential salivary biomarker for OPC using proteomics approach. Materials and methods: OPC cases were enrolled in different cohorts depending on the tobacco consumption habits as smokers, chewers, smokers and chewers and no tobacco consumers. Healthy controls without any tobacco consumption habits were enrolled simultaneously. Tandem Mass Tag based relative quantification was done to identify the cancer related dysregulated proteins. Dysregulated proteins were validated further in a larger cohort of cases and controls. Furthermore, the tissue expression of AHSG was analysed using the TCGA data available on cBioportal and GEPIA2. Results: 171 proteins were identified of which 135 proteins were dysregulated with ≥2-fold change. Differential expression of proteins in different OPC study cohorts was observed. 15 candidate proteins were selected for validation after analysing the data. AHSG (alpha-2HS-glycoprotein) was one of the candidates, validated in a separate larger cohort of cases and controls and was found to be significantly elevated in cases. AHSG was also found to be upregulated in the tumor tissue of HNSCC patients and patients with low AHSG were found to have the better overall survival outcome in comparison to the cases with higher AHSG. Conclusions: AHSG levels are elevated in saliva of OPC cases compared to non-OPC healthy controls. This expression pattern of AHSG should be evaluated further as a potential biomarker for OPC.http://www.sciencedirect.com/science/article/pii/S2772906024003248
spellingShingle Anu Jain
Aafaque Ahmad Khan
Rajandeep Kaur
Roshan K Verma
Jaimanti Bakshi
Aditi Chatterjee
Amanjit Bal
Sushmita Ghoshal
Arnab Pal
A proteomic analysis identifies higher AHSG (Alpha-2-HS-glycoprotein) in saliva of oropharyngeal cancer patients – A potential salivary biomarker
Oral Oncology Reports
title A proteomic analysis identifies higher AHSG (Alpha-2-HS-glycoprotein) in saliva of oropharyngeal cancer patients – A potential salivary biomarker
title_full A proteomic analysis identifies higher AHSG (Alpha-2-HS-glycoprotein) in saliva of oropharyngeal cancer patients – A potential salivary biomarker
title_fullStr A proteomic analysis identifies higher AHSG (Alpha-2-HS-glycoprotein) in saliva of oropharyngeal cancer patients – A potential salivary biomarker
title_full_unstemmed A proteomic analysis identifies higher AHSG (Alpha-2-HS-glycoprotein) in saliva of oropharyngeal cancer patients – A potential salivary biomarker
title_short A proteomic analysis identifies higher AHSG (Alpha-2-HS-glycoprotein) in saliva of oropharyngeal cancer patients – A potential salivary biomarker
title_sort proteomic analysis identifies higher ahsg alpha 2 hs glycoprotein in saliva of oropharyngeal cancer patients a potential salivary biomarker
url http://www.sciencedirect.com/science/article/pii/S2772906024003248
work_keys_str_mv AT anujain aproteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT aafaqueahmadkhan aproteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT rajandeepkaur aproteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT roshankverma aproteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT jaimantibakshi aproteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT aditichatterjee aproteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT amanjitbal aproteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT sushmitaghoshal aproteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT arnabpal aproteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT anujain proteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT aafaqueahmadkhan proteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT rajandeepkaur proteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT roshankverma proteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT jaimantibakshi proteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT aditichatterjee proteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT amanjitbal proteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT sushmitaghoshal proteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker
AT arnabpal proteomicanalysisidentifieshigherahsgalpha2hsglycoproteininsalivaoforopharyngealcancerpatientsapotentialsalivarybiomarker